Protara Therapeutics (TARA) Debt Ratio (2020)

Protara Therapeutics (TARA) posted quarterly Debt Ratio of 0.0 for Q3 2020, down 87.28% quarter-over-quarter from 0.01 in Q2 2020.

Protara Therapeutics (TARA) Debt Ratio (2020) Analysis & Trends

Protara Therapeutics (TARA) has reported Debt Ratio for 1 consecutive years, with 0.0 the latest figure, recorded in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	0.05
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	0.12
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.47
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	0.26
10	Protara Therapeutics	234.56 Mn	234.56 Mn	-	-

Download Data